Search clinical trials for: Healthy adult participants (aged 50 to 69 years)

Total 478603 results

Charite University, Berlin, Germany

Completed

Effects of Brain Stimulation During a Daytime Nap on Memory Consolidation in Older Adults

Older Adults (50-90 Years)

Germany
Immorna Biotherapeutics, Inc.
ICON plc

Active, not recruiting

A First-in-Human Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine (JCXH-105)

Infectious Disease | Shingles | Herpes Zoster (HZ)

United States
Vrije Universiteit Brussel
University Ghent; Research Foundation Flanders

Completed

The Impact of Grandchild Care on Physical Activity and Sedentary Behavior in People Aged 50 Years and Over

Adults Aged 50 Years and Older

Belgium
UCB Pharma

Completed

Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study (CERTAIN 2)

Rheumatoid Arthritis

Poland, Germany, Austria, France, Italy
EuBiologics Co.,Ltd

Not yet recruiting

Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years

Herpes Zoster | Varicella Zoster Virus Infection
University of Erlangen-Nürnberg Medical School
University of Erlangen-Nürnberg; Klinikum Nürnberg; Institute of Physical Education...

Completed

Running Effect on Cardiovascular and Muscular Parameters

Healthy | Males | Untrained | 30-50 Years Old

Germany
UCB Pharma
Pivotal S.L.

Completed

Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine (RETO-PD)

Parkinson's Disease

Spain
UCB Pharma SA

Completed

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis (C-early)

Rheumatoid Arthritis

Germany, United States, Argentina, Australia, Austria, Belgium, Canada, Colombia, Czechia, France, Hungary, Ireland, Italy, Mexico, Monaco, Netherlands, Poland, Romania, Spain, Sweden, Switzerland, United Kingdom
Massachusetts General Hospital

Active, not recruiting

Cognitive Behavior Therapy (CBT)-Based Group Intervention to Reduce Inflammation in Older People With HIV (CHAMP)

HIV | Aging

United States
UCB BIOSCIENCES, Inc.

Completed

Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures (ALEX-MT)

Epilepsy

Austria, United States, Australia, Canada, Denmark, France, Germany, Ireland, Italy, Poland, Puerto Rico, Spain, United Kingdom
UCB Pharma GmbH

Completed

Observation of Treatment With Certolizumab Pegol in Daily Practice (FasT)

Rheumatoid Arthritis

Germany
UCB Pharma SA
Parexel

Completed

Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate

Rheumatoid Arthritis

Romania, United States, Australia, Austria, Bulgaria, Canada, Czechia, France, Germany, Greece, Hungary, Ireland, Italy, Mexico, Monaco, Poland, Portugal, Spain, Switzerland, United Kingdom
UCB Pharma GmbH

Completed

Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic Drug (VITOBA)

Epilepsies, Partial

Germany
UCB Pharma

Completed

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis (C-early)

Rheumatoid Arthritis

Germany, United States, Argentina, Australia, Austria, Belgium, Canada, Colombia, Czechia, France, Hungary, Ireland, Italy, Mexico, Monaco, Netherlands, Poland, Romania, Spain, Sweden, Switzerland, United Kingdom
GlaxoSmithKline

Completed

Safety, Blood Levels and Effects of GW642444

Pulmonary Disease, Chronic Obstructive

United Kingdom
Zhongda Hospital

Unknown

Effects of AN69 ST Hemofilter on Coagulation During Continuous Renal Replacement Therapy in Critically Ill

Septic Shock | Acute Kidney Injury | Critically Ill

China
Cancer Care Ontario
Canadian Institutes of Health Research (CIHR)

Completed

Increasing Colorectal Cancer Screening Uptake With a Patient Navigator

Colorectal Cancer

Canada
VA Office of Research and Development

Recruiting

Asymptomatic Carotid Stenosis and Mobility Function With Exercise Intervention (ACCOF-Ex)

Mobility Impairment | Asymptomatic Carotid Stenosis (50-69%)

United States
Children's Hospital Los Angeles
National Center for Advancing Translational Sciences (NCATS); AltaMed Health...

Suspended

The Impact of Parent Training on the Child's Health Services

Parenting | Child Behavior Problem | Child Rearing

United States
CanSino Biologics Inc.

Active, not recruiting

Clinical Trial of Recombinant Pneumococcal Protein Vaccine

Respiratory Tract Infections | Respiratory Tract Diseases | Pneumonia

China
Regional centre for children and youth mental health...

Completed

Evaluating a Shortened Version of the Incredible Years (IY) Basic Programme in a Non-clinical Community Sample

Child Behavior Problems | Parenting Behavior
Castle Creek Pharmaceuticals, LLC

Completed

Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex

Epidermolysis Bullosa | Epidermolysis Bullosa Simplex

United States
ANS Pharma
University of Campinas, Brazil; Conselho Nacional de Desenvolvimento Científico...

Completed

Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin

Diabetes Mellitus, Type 2 | Diabetes Mellitus | Complications of Diabetes Mellitus

Brazil
Acute Leukemia French Association
Versailles Hospital

Completed

A Randomized Study of Gemtuzumab Ozogamicin (GO) With Daunorubicine and Cytarabine in Untreated Acute Myeloid Leukemia (AML) Aged of 50-70 Years Old

Acute Myeloid Leukemia

France
Novartis
Novartis Vaccines

Completed

Immunogenicity, Safety and Tolerability of a Trivalent Subunit Inactivated Vaccine in Healthy Subjects 50 Years and Above

Influenza

Czech Republic, Philippines, South Africa, Thailand
Overseas Pharmaceuticals, Ltd.
GX pharma technology (beijing) Co., Ltd

Active, not recruiting

An Open Label, Balanced, Randomized, 3×3 Latin Square Design Comparing of Brivaracetam Sustained-release Tablets and Brivaracetam Tablets in the Oral Comparative Pharmacokinetic(PK) Study in Chinese Healthy Adult Subjects Under Fasting Conditions.

Partial Seizure

China
GlaxoSmithKline

Completed

Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older

Herpes Zoster

United States, Estonia
EA Pharma Co., Ltd.

Active, not recruiting

A Study of E6011 in Participants With Active Crohn's Disease

Crohn's Disease

Czechia, Hungary, Japan, Poland, Russian Federation
Fundació Sant Joan de Déu

Unknown

Implementation of Incredible Years for Autism and Language Delay Program in Spain (FS)

Autism Spectrum Disorder | Prematurity | Language Delay

Spain
UCB Pharma

Completed

Caregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver Support (CARE-ACT)

Idiopathic Parkinson's Disease

Germany
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A When Administered Subcutaneously Intramuscularly in Adults Aged ≥50 Years

Herpes Zoster

Japan
French Cardiology Society
AstraZeneca; Daiichi Sankyo, Inc.; Boston Scientific Corporation; Abbott Medical... and other collaborators

Completed

WAMIF : Young Women Presenting Acute Myocardial Infarction in France (WAMIF)

Acute Myocardial Infarction | Women Over 18 and Under 50 Years of Age

France
Tufts Medical Center
National Institute of Mental Health (NIMH)

Completed

Parent Training to Promote Early Identification and Treatment of Childhood Behavioral Disorders

Attention Deficit and Disruptive Behavior Disorders | Attention Deficit Disorder With Hyperactivity

United States
GlaxoSmithKline

Completed

Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older

Herpes Zoster

United States, Australia, Spain, Finland, Germany, Japan, Taiwan, Canada, Sweden, Korea, Republic of, Czechia, Hong Kong, Mexico, Italy, Brazil, Estonia, France, United Kingdom
University Hospital, Brest
University Hospital, Antwerp; Leiden University Medical Center; Insel Gruppe...

Recruiting

Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspected Pulmonary Embolism in Patients With Malignancy (HYDRA)

Cardiovascular Diseases | Vascular Diseases | Respiratory Tract Diseases | Lung Diseases | Cancer | Embolism | Embolism and Thrombosis | Pulmonary Embolism | Diagnosis

Netherlands, Spain, France, Switzerland, Italy, Belgium
Lotus Pharmaceutical

Unknown

A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus

The Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg | Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in | Subjects With Type 2 Diabetes Mellitus.

Taiwan
Gilead Sciences

Completed

A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects

HIV Infections

France, Spain, United Kingdom, Belgium, Italy, Germany, Netherlands, Portugal, Austria, Ireland, Poland, Sweden, Switzerland
Pierre Fabre Pharma GmbH
Pierre Fabre Pharma Austria; Pierre Fabre Pharma AG

Recruiting

Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment (BERING)

Melanoma Stage IV | Melanoma Stage III

Austria, Germany, Switzerland
Mycovia Pharmaceuticals Inc.

Completed

Study of Oral Oteseconazole (VT-1161) for Acute Yeast Infections in Patients With Recurrent Yeast Infections (ultraVIOLET)

Recurrent Vulvovaginal Candidiasis

United States
InDex Pharmaceuticals

Completed

The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis (CONDUCT)

Ulcerative Colitis

Hungary, Czechia, France, Germany, Poland, Russian Federation, Serbia, Spain, Sweden, Ukraine
UCB Biopharma S.P.R.L.
Parexel

Completed

A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life (CIMAX)

Axial Spondyloarthritis

Belgium, Germany, Greece, Italy, Spain, United Kingdom
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Harvard Atherosclerosis Reversibility Project (HARP)

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease
Cairo University

Completed

The Value of Tranxemic Acid to Reduce Intraoperative Blood Loss During Elective Cesarean Sections in High Risk Women

Intraoperative Bleeding

Egypt
GlaxoSmithKline

Active, not recruiting

Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age.

Sexually Transmitted Diseases

United States, Germany, Philippines, France, Spain, South Africa, United Kingdom, Brazil
Glostrup University Hospital, Copenhagen

Suspended

Antipsychotics and Metabolic Syndrome

Metabolic Syndrome

Denmark
University Hospital, Montpellier

Unknown

Incidence of MRI Sacro-Iliac Joint Anomalies in Young Women (MISIA)

Axial Spondyloarthritis | Women (Between 18 to 50 Years Old) | Sacro-iliac Joints | Inflammatory Lesions | Structural Lesions

France
University of Alabama at Birmingham

Completed

A Resilience Building Intervention to Promote Successful Aging (RISE)

Community Dwelling Adults Aged 50 and Older

United States
Amgen

Active, not recruiting

Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke (VESALIUS-CV)

Coronary Heart Disease (CHD)

Canada, France, United States, Spain, United Kingdom, Korea, Republic of, Netherlands, Austria, Australia, Czechia, Taiwan, Finland, Hungary, Italy, Poland, Greece, Germany, Brazil, Latvia, Denmark, Mexico, Russian Federation, Bulgaria and more
AstraZeneca

Completed

A Phase3 Study to Evaluate the Efficacy and Safety of MEDI3250 in Healthy Japanese Children Age 7 Years Through 18 Years

Healthy Japanese Children Age 7 Years Through 18 Years

Japan
AstraZeneca

Completed

A Phase 3 Open-label Study to Evaluate the Safety of MEDI3250 in Healthy Japanese Children Age 2 Years Through 6 Years

Healthy Japanese Children Age 2 Years Through 6 Years

Japan

Search clinical trials for: Healthy adult participants (aged 50 to 69 years)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations